Catheter ablation in supraventricular tachycardia.
The evolution of catheter ablation for the treatment of supraventricular tachycardias represents a major advance in the management of cardiac arrhythmias. Excellent results in the majority of patients undergoing the procedure, together with a low rate of early complications and a brief hospitalization, make catheter ablation a highly cost-effective permanent cure. At present, however, its place in relation to alternate therapies in the management of supraventricular tachycardias has not been clearly established owing to unresolved risk-benefit issues. Continuing technical advances will likely enable catheter ablation to be successfully applied to a broader range of cardiac arrhythmias.
Deshpande
S
S
Wisconsin Electrophysiology Group, Milwaukee Heart Institute of Sinai Samaritan Medical Center, USA.
Jazayeri
M
M
Dhala
A
A
Blanck
Z
Z
Sra
J
J
Bremner
S
S
Akhtar
M
M
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001283:Atrioventricular Node / Q000503:physiopathology / Q000601:surgery; D017115:Catheter Ablation / Q000191:economics / Q000295:instrumentation*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D004562:Electrocardiography / Q000145:classification; D006801:Humans; D013617:Tachycardia, Supraventricular / Q000145:classification / Q000503:physiopathology / Q000601:surgery*
D000889:Anti-Arrhythmia Agents